Annual CAPEX
$995.00 K
-$1.53 M-60.58%
December 31, 2023
Summary
- As of February 20, 2025, AQST annual capital expenditures is $995.00 thousand, with the most recent change of -$1.53 million (-60.58%) on December 31, 2023.
- During the last 3 years, AQST annual CAPEX has risen by +$478.00 thousand (+92.46%).
- AQST annual CAPEX is now -60.58% below its all-time high of $2.52 million, reached on December 31, 2022.
Performance
AQST CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$80.00 K
+$45.00 K+128.57%
September 30, 2024
Summary
- As of February 20, 2025, AQST quarterly capital expenditures is $80.00 thousand, with the most recent change of +$45.00 thousand (+128.57%) on September 30, 2024.
- Over the past year, AQST quarterly CAPEX has dropped by -$71.00 thousand (-47.02%).
- AQST quarterly CAPEX is now -95.34% below its all-time high of $1.72 million, reached on September 30, 2022.
Performance
AQST Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$160.00 K
-$71.00 K-30.74%
September 30, 2024
Summary
- As of February 20, 2025, AQST TTM capital expenditures is $160.00 thousand, with the most recent change of -$71.00 thousand (-30.74%) on September 30, 2024.
- Over the past year, AQST TTM CAPEX has dropped by -$845.00 thousand (-84.08%).
- AQST TTM CAPEX is now -94.72% below its all-time high of $3.03 million, reached on September 30, 2022.
Performance
AQST TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
AQST CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -60.6% | -47.0% | -84.1% |
| 3 y3 years | +92.5% | -47.0% | -84.1% |
| 5 y5 years | -45.5% | -47.0% | -84.1% |
AQST CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -60.6% | +9.0% | -95.3% | +3900.0% | -94.7% | at low |
| 5 y | 5-year | -60.6% | +92.5% | -95.3% | +3900.0% | -94.7% | at low |
| alltime | all time | -60.6% | +92.5% | -95.3% | +3900.0% | -94.7% | at low |
Aquestive Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $80.00 K(+128.6%) | $160.00 K(-30.7%) |
| Jun 2024 | - | $35.00 K(+20.7%) | $231.00 K(-77.4%) |
| Mar 2024 | - | $29.00 K(+81.3%) | $1.02 M(+2.7%) |
| Dec 2023 | $995.00 K(-60.6%) | $16.00 K(-89.4%) | $995.00 K(-1.0%) |
| Sep 2023 | - | $151.00 K(-81.7%) | $1.00 M(-60.9%) |
| Jun 2023 | - | $826.00 K(>+9900.0%) | $2.57 M(+6.2%) |
| Mar 2023 | - | $2000.00(-92.3%) | $2.42 M(-4.0%) |
| Dec 2022 | $2.52 M(+176.5%) | $26.00 K(-98.5%) | $2.52 M(-16.7%) |
| Sep 2022 | - | $1.72 M(+153.6%) | $3.03 M(+117.0%) |
| Jun 2022 | - | $677.00 K(+551.0%) | $1.40 M(+52.8%) |
| Mar 2022 | - | $104.00 K(-80.5%) | $914.00 K(+0.1%) |
| Dec 2021 | $913.00 K(+76.6%) | $533.00 K(+542.2%) | $913.00 K(+48.2%) |
| Sep 2021 | - | $83.00 K(-57.2%) | $616.00 K(+7.9%) |
| Jun 2021 | - | $194.00 K(+88.3%) | $571.00 K(+16.8%) |
| Mar 2021 | - | $103.00 K(-56.4%) | $489.00 K(-5.4%) |
| Dec 2020 | $517.00 K | $236.00 K(+521.1%) | $517.00 K(+40.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $38.00 K(-66.1%) | $367.00 K(-12.6%) |
| Jun 2020 | - | $112.00 K(-14.5%) | $420.00 K(+0.5%) |
| Mar 2020 | - | $131.00 K(+52.3%) | $418.00 K(-37.0%) |
| Dec 2019 | $663.00 K(-63.7%) | $86.00 K(-5.5%) | $663.00 K(-37.9%) |
| Sep 2019 | - | $91.00 K(-17.3%) | $1.07 M(-25.1%) |
| Jun 2019 | - | $110.00 K(-70.7%) | $1.42 M(-26.6%) |
| Mar 2019 | - | $376.00 K(-23.3%) | $1.94 M(+6.4%) |
| Dec 2018 | $1.82 M(-11.8%) | $490.00 K(+9.4%) | $1.82 M(+28.3%) |
| Sep 2018 | - | $448.00 K(-28.5%) | $1.42 M(+1.1%) |
| Jun 2018 | - | $627.00 K(+142.1%) | $1.41 M(-15.7%) |
| Mar 2018 | - | $259.00 K(+194.3%) | $1.67 M(-19.2%) |
| Dec 2017 | $2.07 M(+111.9%) | $88.00 K(-79.7%) | $2.07 M(+4.4%) |
| Sep 2017 | - | $433.00 K(-51.3%) | $1.98 M(+28.0%) |
| Jun 2017 | - | $890.00 K(+35.5%) | $1.55 M(+135.5%) |
| Mar 2017 | - | $657.00 K | $657.00 K |
| Dec 2016 | $976.00 K | - | - |
FAQ
- What is Aquestive Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Aquestive Therapeutics?
- What is Aquestive Therapeutics annual CAPEX year-on-year change?
- What is Aquestive Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Aquestive Therapeutics?
- What is Aquestive Therapeutics quarterly CAPEX year-on-year change?
- What is Aquestive Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Aquestive Therapeutics?
- What is Aquestive Therapeutics TTM CAPEX year-on-year change?
What is Aquestive Therapeutics annual capital expenditures?
The current annual CAPEX of AQST is $995.00 K
What is the all time high annual CAPEX for Aquestive Therapeutics?
Aquestive Therapeutics all-time high annual capital expenditures is $2.52 M
What is Aquestive Therapeutics annual CAPEX year-on-year change?
Over the past year, AQST annual capital expenditures has changed by -$1.53 M (-60.58%)
What is Aquestive Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of AQST is $80.00 K
What is the all time high quarterly CAPEX for Aquestive Therapeutics?
Aquestive Therapeutics all-time high quarterly capital expenditures is $1.72 M
What is Aquestive Therapeutics quarterly CAPEX year-on-year change?
Over the past year, AQST quarterly capital expenditures has changed by -$71.00 K (-47.02%)
What is Aquestive Therapeutics TTM capital expenditures?
The current TTM CAPEX of AQST is $160.00 K
What is the all time high TTM CAPEX for Aquestive Therapeutics?
Aquestive Therapeutics all-time high TTM capital expenditures is $3.03 M
What is Aquestive Therapeutics TTM CAPEX year-on-year change?
Over the past year, AQST TTM capital expenditures has changed by -$845.00 K (-84.08%)